Comparison of Anti–pd-L1 with Anti–pd-1 Antibodies in the Combination of HAIC and Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma.
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined